Analyses / Public Summary / 119 · HRES 872 Public Summary

119-HRES-872 Journalist Public Summary

119 · HRES 872 Supporting the goals and ideals of "Creutzfeldt-Jakob Disease (CJD) Awareness Day".

A bipartisan House resolution introduced November 10, 2025, supports recognizing November 12, 2025, as Creutzfeldt–Jakob Disease (CJD) Awareness Day. It’s symbolic—no new funding or law—but aims to highlight a rare, rapidly fatal brain disease and the value of public-health surveillance. The measure was referred to the House Energy and Commerce Committee; if adopted, it would state the House’s support and raise visibility for patients, families, and researchers.

Published
11 Nov 2025
Updated
17 Nov 2025
Tags
Public Summary · House Resolution · Health
Unvetted
01 · Section

Headline Summary

A bipartisan House resolution would recognize November 12, 2025, as “Creutzfeldt–Jakob Disease (CJD) Awareness Day,” spotlighting a rare but deadly brain disease and the importance of monitoring it.

02 · Section

What It Does

H. Res. 872 is a simple House resolution that expresses support for the goals and ideals of CJD Awareness Day. It raises awareness of CJD and other prion diseases, underscores the need for surveillance (including postmortem testing), and acknowledges the role of the National Prion Disease Pathology Surveillance Center. It does not change law, appropriate money, or create new programs.

Incidence noted
1–2 cases per 1,000,000 people annually (about 600 U.S. cases/year)
Case types
85% sporadic; 10–15% genetic; <1% acquired
Typical course
12months or less from symptom onset to death (often a few months)
CWD spread in cervids
36+ states with detections (deer/elk/moose)
03 · Section

Who’s For It

  • Bipartisan House sponsors and co-sponsors: led by Rep. David Valadao, with Reps. Joyce (OH), Fong, Bean (FL), Nadler, Brown, Brownley, Buchanan, Swalwell, Tonko, and Costa listed on introduction.
  • Likely supporters include patients, families, and rare-disease/public‑health advocates who want more awareness and strong national surveillance for prion diseases.
04 · Section

Who’s Against It

  • No organized opposition identified in the measure’s introduction.
  • Potential critiques: awareness resolutions are symbolic and do not fund research, caregiver support, or surveillance capacity.
05 · Section

What’s Next

Status as of November 10, 2025: referred to the House Committee on Energy and Commerce. The committee may take it up for consideration; if the House adopts it (often by voice vote for noncontroversial items), it becomes an official statement of the House’s support. No Senate or presidential action is required.

Discussion